Mirum Pharmaceuticals, Inc.

By person

13 insiders · 64 transactions

74.1×

Christopher Peetz holds 74.1 times base salary in stock. $56.02M of shares against $755.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Christopher Peetz last reported holding, valued at $98.37, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Peetz Christopher

CHIEF EXECUTIVE OFFICER

—

$16.29M (19) scheduled

−$16.29M

569,440

0.8770%

$56.02M

+8.8%

GREY MICHAEL G

Director

—

$11.10M (3) scheduled

−$11.10M

186,410

0.2871%

$18.34M

−35.5%

Heron Patrick J

Director

$9.00M (1)

—

+$9.00M

464,713

0.7157%

$45.71M

+187.2%

Howe Jolanda

SVP, GLOBAL CONTROLLER

—

$5.55M (9) scheduled

−$5.55M

616

0.0009%

$60.60K

−74.6%

BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

—

$3.56M (12)

−$3.56M

44,745

0.0689%

$4.40M

+33.4%

Radovich Peter

PRESIDENT AND COO

—

$2.32M (4)

−$2.32M

57,260

0.0882%

$5.63M

+95.9%

Ramasastry Saira

Director

—

$1.92M (9) scheduled

−$1.92M

0.0000%

$0.00

—

Quan Joanne

CHIEF MEDICAL OFFICER

—

$1.46M (3)

−$1.46M

18,864

0.0291%

$1.86M

+28,055%

Brege Laura

Director

—

15,703

0.0242%

$1.54M

+57.0%

Fischer Laurent

Director

—

10,727

0.0165%

$1.06M

+58.9%

Walbert Timothy P

Director

—

9,680

0.0149%

$952.22K

—

Cardon Lon

Director

—

9,680

0.0149%

$952.22K

—

Fairey William

Director

—

2,500

0.0039%

$245.93K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Peetz Christopher

1 Sep 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

21,688

$98.91

$2.15M

Peetz Christopher

1 Sep 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

8,312

$98.08

$815.24K

Howe Jolanda

18 Aug 2026

SVP, GLOBAL CONTROLLER

Sold after exercise

40,000

$100.00

$4.00M

Peetz Christopher

10 Aug 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

2,300

$100.14

$230.32K

Peetz Christopher

10 Aug 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

6,017

$99.25

$597.19K

Peetz Christopher

10 Aug 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

11,683

$98.51

$1.15M

Peetz Christopher

6 Jul 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

1,710

$124.79

$213.39K

Peetz Christopher

6 Jul 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

1,975

$123.74

$244.39K

Peetz Christopher

6 Jul 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

4,181

$122.34

$511.50K

Peetz Christopher

6 Jul 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

12,134

$121.65

$1.48M

Peetz Christopher

1 Jun 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

883

$99.66

$88.00K

Peetz Christopher

1 Jun 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

1,021

$98.20

$100.26K

Peetz Christopher

1 Jun 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

1,973

$97.56

$192.49K

Peetz Christopher

1 Jun 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

6,926

$96.15

$665.93K

Peetz Christopher

1 Jun 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

16,595

$95.34

$1.58M

Peetz Christopher

1 Jun 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

2,602

$94.64

$246.25K

Ramasastry Saira

15 May 2026

Director

Sold after exercise

2,000

$109.47

$218.94K

Ramasastry Saira

15 Apr 2026

Director

Sold after exercise

2,000

$96.90

$193.80K

Ramasastry Saira

16 Mar 2026

Director

Sold after exercise

2,000

$90.76

$181.52K

Ramasastry Saira

13 Feb 2026

Director

Sold after exercise

2,000

$102.09

$204.18K

Ramasastry Saira

15 Jan 2026

Director

Sold after exercise

2,000

$90.99

$181.98K

Ramasastry Saira

22 Dec 2025

Director

Sold after exercise

5,000

$80.00

$400.00K

GREY MICHAEL G

19 Dec 2025

Director

Sold after exercise

50,000

$78.00

$3.90M

Ramasastry Saira

18 Dec 2025

Director

Sold after exercise

1,000

$70.00

$70.00K

Ramasastry Saira

18 Dec 2025

Director

Sold after exercise

1,000

$69.46

$69.46K

GREY MICHAEL G

1 Dec 2025

Director

Sold after exercise

50,000

$74.00

$3.70M

GREY MICHAEL G

21 Nov 2025

Director

Sold after exercise

50,000

$70.00

$3.50M

Show all 64 transactions →

Mirum Pharmaceuticals, Inc.

By person

Individual transactions

What was left out